Feedback / Questions
rusfertide (PTG-300) - Protagonist Therap, Takeda
Rusfertide: Launch in US for polycythemia vera in 2026
(Protagonist Therapeutics)
-
Aug 15, 2024 -
Corporate Presentation
Launch US
•
Hematological Malignancies • Myeloproliferative Neoplasm • Oncology • Polycythemia Vera
https://irp.cdn-website.com/8e9b9820/files/uploaded/2024_PTGX_CorpDeck_06Aug2024_FINAL.pdf
Aug 15, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious